Skip to main navigation Skip to search Skip to main content

C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses

  • H. Kunugi
  • , R. Fukuda
  • , M. Hattori
  • , T. Kato
  • , M. Tatsumi
  • , T. Sakai
  • , T. Hirose
  • , S. Manko
  • Showa Medical University
  • The University of Tokyo
  • Teikyo University

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Abstract

A common missense mutation of the methylenetetrahydrofolate reductase (MTHFR) gene (C677T) has been shown to be a risk factor for premature cardiovascular disease and neural tube defect. Deficient activity of MTHFR has also been implicated in the pathogenesis of psychiatric conditions such as schizophrenia and affective disorders. Arinami et al found an increased frequency of homozygosity for the mutated type (T677) of the MTHFR gene in schizophrenia and depression. We tried to replicate this finding in a sample of 343 patients with schizophrenia, 143 with bipolar disorder, 71 with unipolar depression, and 258 controls; however, there was no significantly increased frequency of homozygosity for the T677 allele in any of the diagnostic groups, compared to the controls. Our results suggest that homozygosity for the T677 allele of the MTHFR gene is unlikely to play a major role in the pathogenesis of schizophrenia or affective disorders in our sample.

Original languageEnglish
Pages (from-to)435-437
Number of pages3
JournalMolecular Psychiatry
Volume3
Issue number5
DOIs
StatePublished - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Association study
  • Bipolar disorder
  • Depression
  • Genetics
  • Homocysteinuria
  • Methylenetetrahydrofolate reductase
  • Schizophrenia

Fingerprint

Dive into the research topics of 'C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses'. Together they form a unique fingerprint.

Cite this